50%

ICM DOSE REDUCTION

Our completed clinical study demonstrates that the quality reserve provided by our technology can be effectively converted to significant contrast media (50%) reduction in carotid angiography. This brings significant economical and health benefits - less adverse events, contrast induced nephropathy - to the patients and cost saving for the cath labs. The clinical study was published in the European Journal of Radiology Open.

Carotid angiographyBelow the knee selective diagnostic angiography
GE Innova IGS 530 · ICM: Xenetix 350 mg iodine/mL:1 ml/s, 2 ml ICM protocol with 2 fps:

Low doseLow dose
DVA * 3 ml bolusDVA * 2 ml bolus

PEER REVIEWED PUBLICATIONS ABOUT 50% ICM REDUCTION

Initial evidence of a 50% reduction of contrast media using Digital Varience Angiography in endovascular carotid interventions

Viktor I. Oriás, David Szöllősi, Marcell Gyánó, Dániel S. Veres, Sándor Nardai, Csaba Csobay-Nová..

SEE ALL PUBLICATIONS

ICM DOSE REDUCTION

PEER REVIEWED PUBLICATIONS ABOUT 50% ICM REDUCTION

Initial evidence of a 50% reduction of contrast media using Digital Varience Angiography in endovascular carotid interventions

Substantial x-ray dose reduction

Increased diagnostic insight

1026 Budapest,
Szilágyi Erzsébet fasor
31. 2. em. 12.